Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Accounts Payables: 2010-2025

Historic Accounts Payables for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $27.7 million.

  • ProPhase Labs' Accounts Payables rose 79.18% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 79.18%. This contributed to the annual value of $13.7 million for FY2024, which is 58.69% up from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Accounts Payables is $27.7 million, which was up 84.27% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Accounts Payables ranged from a high of $27.7 million in Q3 2025 and a low of $1.5 million during Q3 2022.
  • Its 3-year average for Accounts Payables is $12.2 million, with a median of $13.3 million in 2025.
  • In the last 5 years, ProPhase Labs' Accounts Payables surged by 1,019.42% in 2021 and then tumbled by 40.69% in 2023.
  • Over the past 5 years, ProPhase Labs' Accounts Payables (Quarterly) stood at $7.0 million in 2021, then dropped by 15.96% to $5.9 million in 2022, then spiked by 46.38% to $8.6 million in 2023, then skyrocketed by 58.69% to $13.7 million in 2024, then spiked by 79.18% to $27.7 million in 2025.
  • Its Accounts Payables was $27.7 million in Q3 2025, compared to $15.0 million in Q2 2025 and $13.3 million in Q1 2025.